Questions Raised In Vietnam About Pair Of HPV Vaccine Approvals
This article was originally published in PharmAsia News
Executive Summary
Vietnam authorities are looking into suspicions medical companies lobbied the government unethically to approve two vaccines against cervical cancer. They include Merck's Gardasil and GlaxoSmithKline's Cervarix. Vietnamese cancer associations are raising questions about the lobbying during the approval process for vaccines that may not be as effective as touted in staving off the human papilloma virus often responsible for cervical cancer. A GSK official said its application was the same it has sent to approval authorities in other countries and it made no special effort in Vietnam. But a Health Ministry official said Vietnam should consider the questions about effectiveness of both vaccines and continue to restrict it for women between ages 10 and 55. (Click here for more
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.